Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alaaeldin Shalaby

Clinical Cardiac Electrophysiology Pittsburgh, PA Medical Doctor

NPI 1316912595 CMS profile 1288197

200 Lothrop St, Wing 5B Puh, Pittsburgh, PA 15213

Open in the dashboard

General payments

$34,080

173 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$153,715 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Alaaeldin Shalaby of Pittsburgh, PA is reported in the CMS Open Payments database as having received $34,080 across 173 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $153,715 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 65th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $16,575 49
2024 General $7,169 56
2023 General $4,507 31
2022 General $2,354 19
2020 General $1,780 8
2019 General $1,696 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alaaeldin Shalaby
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Alaaeldin Shalaby were reported at $16,575. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Alaaeldin Shalaby Clinical Cardiac Electrophysiology median Middle half National median
2019 $1,696 $2,361 $585–$8,260 $163
2020 $1,780 $993 $247–$4,351 $114
2021 $0 $1,185 $326–$4,739 $132
2022 $2,354 $2,073 $554–$6,789 $149
2023 $4,507 $2,568 $759–$8,159 $160
2024 $7,169 $2,557 $703–$7,403 $164
2025 $16,575 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $13,748 53 payments
  2. Medtronic, Inc. $9,287 71 payments
  3. Boston Scientific Corporation $4,449 12 payments
  4. Medtronic Vascular, Inc. $2,626 15 payments
  5. Atricure, Inc. $1,651 7 payments
  6. Biotronik Inc. $1,093 2 payments
  7. CardioFocus, Inc. $849 3 payments
  8. Cardiva Medical, Inc. $107 4 payments
  9. Siemens Medical Solutions USA, Inc. $105 2 payments
  10. Biosense Webster, Inc. $82 1 payment
  11. Other $82 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $14,792 56 payments
  2. Consulting Fee $8,913 9 payments
  3. Food and Beverage $6,478 106 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,750 1 payment
  5. Grant $147 1 payment
Products named General payments · program years 2019–2025
  1. GALLANT $4,888 5 payments
  2. AVEIR Structural Heart $4,504 5 payments
  3. General - Therapies $3,750 1 payment
  4. Micra Pacemakers $2,854 16 payments
  5. AURORA EV-ICD MRI SURESCAN $1,910 19 payments
  6. Arctic Front $1,780 8 payments
  7. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $1,651 7 payments
  8. AVEIR Cardiac Rhythm Management $1,593 9 payments
  9. AVEIR Cardiac Rhythm Management $1,020 8 payments
  10. MICRA Pacemakers $710 6 payments
  11. Other $2,906 52 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

215

Median for Cardiology: 2,533

Drug cost

$74,505

Median for Cardiology: $485,213

Branded share of claims

36.3%

Median for Cardiology: 25.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 56 $56,777
Xarelto Rivaroxaban Brand 11 $13,070
Dofetilide Generic 13 $2,478
Bisoprolol Fumarate Generic 15 $711
Amiodarone Hcl Generic 44 $670
Metoprolol Succinate Generic 49 $544
Metoprolol Tartrate Generic 16 $150
Sotalol Sotalol Hcl Brand 11 $106

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,782 Part D prescribers listed as Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 60 billing codes

Paid by Medicare

$48,048

Medicare's payments for the services billed

Medicare patients

221

Average age 72

Services billed

471

79 women, 142 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 64%
Ischemic heart disease 60%
Arthritis 60%
Heart failure 54%
Diabetes 46%
Chronic kidney disease 45%
COPD 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

173 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record